VBI Vaccines, Inc. – (NASDAQ:VBIV) was up 1.9% on Wednesday . The company traded as high as $3.75 and last traded at $3.68, with a volume of 69,727 shares trading hands. The stock had previously closed at $3.61.

Separately, Ladenburg Thalmann started coverage on shares of VBI Vaccines, Inc. – in a research note on Tuesday, July 26th. They set a “buy” rating on the stock.

The company’s market cap is $119.67 million. The firm’s 50 day moving average price is $3.80 and its 200 day moving average price is $3.93.

VBI Vaccines Inc, formerly SciVac Therapeutics Inc, is a biotechnology company. The Company is engaged in developing various technologies that focus on vaccine protection. It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines. It is involved in various projects related to human cytomegalovirus (CMV) and other antigens.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.